Q4 2024 Yunji Inc Earnings Call Transcript
Key Points
- Yunji Inc (YJ) achieved an improved overall gross margin of 49.4% in 2024, indicating strong profitability.
- The user repurchase rate remained robust at 71.9%, reflecting high customer loyalty and satisfaction.
- The company's private label organic health products, such as probiotic bolus and slimming coffee, have gained significant consumer trust and generated substantial sales.
- Yunji Inc (YJ) successfully launched the SUYE Pro-Ascen firming series, generating over RMB20 million in sales, demonstrating strong demand for their skincare solutions.
- The Jianxin Tea Therapy Program showed promising results during its trial phase, with a 91% return rate among participants, indicating strong user engagement and loyalty.
- Total revenue decreased to RMB97.1 million from RMB149.1 million a year ago, indicating a decline in sales performance.
- The company experienced an increase in general and administrative expenses to RMB71.1 million, primarily due to severance payments and impairment charges.
- Net loss widened to RMB85 million compared to RMB65.9 million a year ago, reflecting financial challenges.
- Operating expenses increased to RMB126.2 million from RMB109.8 million in the same period of 2023, impacting profitability.
- Despite strategic cost-saving measures, near-term expenses such as severance costs partially offset the benefits, affecting the bottom line.
Good morning, and good evening, ladies and gentlemen. Thank you for standing by, and welcome to Yunji's fourth-quarter 2024 earnings conference call. With us today are Mr. Shanglue Xiao, Chairman and Chief Executive Officer; along with Mr. Yeqing Cui, Senior Financial Director.
As a reminder, this conference call is being recorded. Before we start, please note that this call will contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are based on the company's current expectations and current market operating conditions and relate to events that involve known or unknown risks and uncertainties or other factors of Yunji and its industry.
These forward-looking statements can be identified by the terminologies such as will, expect, anticipate, continue, and other similar expressions. For a detailed discussion of these risks and uncertainties, please refer to the company's related documents filed with US SEC.
Any forward-looking statements that the company makes on this call are based on assumptions as of today and are
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
